Research workspace · registry aware
Cancer Research Platform
A pipeline-guided workspace for molecular characterization, evidence exchange, and reproducible research reporting.
Cancer Discovery Pipeline
Seven-stage research framework- Data
- Molecular state
- Biomarkers
- Vulnerabilities
- Pharmacology
- Validation
- Report
Evidence
Published evidence, only when immutable records exist.
This view intentionally remains empty until validated releases and artifact envelopes are registered. Scaffold declarations never become result cards by themselves.
Release evidence
Immutable module releases
Awaiting registry records
No publishable releases are registered
There are no completed runs, validated results, or downloadable reports to present for the registered modules.
Artifact evidence
Traceable output envelopes
Every evidence card must resolve to a producer release and its source dependencies.
Awaiting registry records
No artifact envelopes are published
Biomarkers, vulnerabilities, pharmacological support, validation summaries, and reports remain unavailable until real artifact records are registered.
Evidence readiness
Declared schemas are not results.
4 schema contracts are referenced by current modules.
Schema contracts make future evidence interoperable. They do not establish a candidate, score, effect, association, or external validation claim.